Standard treatment-refractory/ineligible small cell lung cancer treated with drug-eluting beads bronchial arterial chemoembolization: a retrospective cohort study

BACKGROUND: Patients with small cell lung cancer (SCLC) are prone to developing refractoriness to standard treatment, and some patients are ineligible for systemic therapy owing to comorbidities or poor pulmonary function. The prognosis of patient with standard treatment-refractory/ineligible (STRI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Sheng, Li, Yuan-Ming, Bie, Zhi-Xin, Li, Xiao-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816754/
https://www.ncbi.nlm.nih.gov/pubmed/36620174
http://dx.doi.org/10.21037/qims-22-530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816754/
https://www.ncbi.nlm.nih.gov/pubmed/36620174
http://dx.doi.org/10.21037/qims-22-530

Ejemplares similares